实验进化过程中SARS-CoV-2的突变率及突变体的出现

IF 3.3 3区 医学 Q2 EVOLUTIONARY BIOLOGY
Massimo Amicone, Vítor Borges, Maria João Alves, Joana Isidro, Líbia Zé-Zé, Sílvia Duarte, Luís Vieira, Raquel Guiomar, João Paulo Gomes, Isabel Gordo
{"title":"实验进化过程中SARS-CoV-2的突变率及突变体的出现","authors":"Massimo Amicone,&nbsp;Vítor Borges,&nbsp;Maria João Alves,&nbsp;Joana Isidro,&nbsp;Líbia Zé-Zé,&nbsp;Sílvia Duarte,&nbsp;Luís Vieira,&nbsp;Raquel Guiomar,&nbsp;João Paulo Gomes,&nbsp;Isabel Gordo","doi":"10.1093/emph/eoac010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>To understand how organisms evolve, it is fundamental to study how mutations emerge and establish. Here, we estimated the rate of mutation accumulation of SARS-CoV-2 <i>in vitro</i> and investigated the repeatability of its evolution when facing a new cell type but no immune or drug pressures.</p><p><strong>Methodology: </strong>We performed experimental evolution with two strains of SARS-CoV-2, one carrying the originally described spike protein (CoV-2-D) and another carrying the D614G mutation that has spread worldwide (CoV-2-G). After 15 passages in Vero cells and whole genome sequencing, we characterized the spectrum and rate of the emerging mutations and looked for evidences of selection across the genomes of both strains.</p><p><strong>Results: </strong>From the frequencies of the mutations accumulated, and excluding the genes with signals of selection, we estimate a spontaneous mutation rate of 1.3 × 10 <sup><i>-</i>6</sup> ± 0.2 × 10<sup>-6</sup> per-base per-infection cycle (mean across both lineages of SARS-CoV-2 ± 2SEM). We further show that mutation accumulation is larger in the CoV-2-D lineage and heterogeneous along the genome, consistent with the action of positive selection on the spike protein, which accumulated five times more mutations than the corresponding genomic average. We also observe the emergence of mutators in the CoV-2-G background, likely linked to mutations in the RNA-dependent RNA polymerase and/or in the error-correcting exonuclease protein.</p><p><strong>Conclusions and implications: </strong>These results provide valuable information on how spontaneous mutations emerge in SARS-CoV-2 and on how selection can shape its genome toward adaptation to new environments. <b>Lay Summary:</b> Each time a virus replicates inside a cell, errors (mutations) occur. Here, via laboratory propagation in cells originally isolated from the kidney epithelium of African green monkeys, we estimated the rate at which the SARS-CoV-2 virus mutates-an important parameter for understanding how it can evolve within and across humans. We also confirm the potential of its Spike protein to adapt to a new environment and report the emergence of mutators-viral populations where mutations occur at a significantly faster rate.</p>","PeriodicalId":12156,"journal":{"name":"Evolution, Medicine, and Public Health","volume":"10 1","pages":"142-155"},"PeriodicalIF":3.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996265/pdf/","citationCount":"81","resultStr":"{\"title\":\"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution.\",\"authors\":\"Massimo Amicone,&nbsp;Vítor Borges,&nbsp;Maria João Alves,&nbsp;Joana Isidro,&nbsp;Líbia Zé-Zé,&nbsp;Sílvia Duarte,&nbsp;Luís Vieira,&nbsp;Raquel Guiomar,&nbsp;João Paulo Gomes,&nbsp;Isabel Gordo\",\"doi\":\"10.1093/emph/eoac010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>To understand how organisms evolve, it is fundamental to study how mutations emerge and establish. Here, we estimated the rate of mutation accumulation of SARS-CoV-2 <i>in vitro</i> and investigated the repeatability of its evolution when facing a new cell type but no immune or drug pressures.</p><p><strong>Methodology: </strong>We performed experimental evolution with two strains of SARS-CoV-2, one carrying the originally described spike protein (CoV-2-D) and another carrying the D614G mutation that has spread worldwide (CoV-2-G). After 15 passages in Vero cells and whole genome sequencing, we characterized the spectrum and rate of the emerging mutations and looked for evidences of selection across the genomes of both strains.</p><p><strong>Results: </strong>From the frequencies of the mutations accumulated, and excluding the genes with signals of selection, we estimate a spontaneous mutation rate of 1.3 × 10 <sup><i>-</i>6</sup> ± 0.2 × 10<sup>-6</sup> per-base per-infection cycle (mean across both lineages of SARS-CoV-2 ± 2SEM). We further show that mutation accumulation is larger in the CoV-2-D lineage and heterogeneous along the genome, consistent with the action of positive selection on the spike protein, which accumulated five times more mutations than the corresponding genomic average. We also observe the emergence of mutators in the CoV-2-G background, likely linked to mutations in the RNA-dependent RNA polymerase and/or in the error-correcting exonuclease protein.</p><p><strong>Conclusions and implications: </strong>These results provide valuable information on how spontaneous mutations emerge in SARS-CoV-2 and on how selection can shape its genome toward adaptation to new environments. <b>Lay Summary:</b> Each time a virus replicates inside a cell, errors (mutations) occur. Here, via laboratory propagation in cells originally isolated from the kidney epithelium of African green monkeys, we estimated the rate at which the SARS-CoV-2 virus mutates-an important parameter for understanding how it can evolve within and across humans. We also confirm the potential of its Spike protein to adapt to a new environment and report the emergence of mutators-viral populations where mutations occur at a significantly faster rate.</p>\",\"PeriodicalId\":12156,\"journal\":{\"name\":\"Evolution, Medicine, and Public Health\",\"volume\":\"10 1\",\"pages\":\"142-155\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996265/pdf/\",\"citationCount\":\"81\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evolution, Medicine, and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/emph/eoac010\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"EVOLUTIONARY BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evolution, Medicine, and Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/emph/eoac010","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"EVOLUTIONARY BIOLOGY","Score":null,"Total":0}
引用次数: 81

摘要

背景和目的:为了了解生物是如何进化的,研究突变是如何出现和建立的是基础。在这里,我们在体外估计了SARS-CoV-2的突变积累率,并研究了在面对新细胞类型但没有免疫或药物压力时其进化的可重复性。方法:我们对两株SARS-CoV-2进行了实验进化,一株携带最初描述的刺突蛋白(CoV-2-D),另一株携带已在全球传播的D614G突变(CoV-2-G)。在Vero细胞中进行15次传代和全基因组测序后,我们对新出现的突变谱和速率进行了表征,并在这两个菌株的基因组中寻找选择的证据。结果:根据累积的突变频率,排除具有选择信号的基因,我们估计每个碱基每个感染周期的自发突变率为1.3 × 10-6±0.2 × 10-6 (SARS-CoV-2±2SEM两个谱系的平均值)。我们进一步发现,CoV-2-D谱系中的突变积累更大,并且在基因组中具有异质性,这与刺突蛋白的正选择作用一致,刺突蛋白的突变积累是相应基因组平均值的5倍。我们还观察到在CoV-2-G背景中出现突变,可能与RNA依赖性RNA聚合酶和/或纠错外切酶蛋白的突变有关。结论和意义:这些结果为SARS-CoV-2的自发突变如何出现以及选择如何塑造其基因组以适应新环境提供了有价值的信息。摘要:每次病毒在细胞内复制时,都会发生错误(突变)。在这里,通过在最初从非洲绿猴肾上皮分离的细胞中进行实验室繁殖,我们估计了SARS-CoV-2病毒的变化率——这是了解它如何在人类内部和跨人类进化的一个重要参数。我们还证实了其Spike蛋白适应新环境的潜力,并报告了突变体的出现-突变发生速度明显更快的病毒种群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution.

Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution.

Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution.

Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution.

Background and objectives: To understand how organisms evolve, it is fundamental to study how mutations emerge and establish. Here, we estimated the rate of mutation accumulation of SARS-CoV-2 in vitro and investigated the repeatability of its evolution when facing a new cell type but no immune or drug pressures.

Methodology: We performed experimental evolution with two strains of SARS-CoV-2, one carrying the originally described spike protein (CoV-2-D) and another carrying the D614G mutation that has spread worldwide (CoV-2-G). After 15 passages in Vero cells and whole genome sequencing, we characterized the spectrum and rate of the emerging mutations and looked for evidences of selection across the genomes of both strains.

Results: From the frequencies of the mutations accumulated, and excluding the genes with signals of selection, we estimate a spontaneous mutation rate of 1.3 × 10 -6 ± 0.2 × 10-6 per-base per-infection cycle (mean across both lineages of SARS-CoV-2 ± 2SEM). We further show that mutation accumulation is larger in the CoV-2-D lineage and heterogeneous along the genome, consistent with the action of positive selection on the spike protein, which accumulated five times more mutations than the corresponding genomic average. We also observe the emergence of mutators in the CoV-2-G background, likely linked to mutations in the RNA-dependent RNA polymerase and/or in the error-correcting exonuclease protein.

Conclusions and implications: These results provide valuable information on how spontaneous mutations emerge in SARS-CoV-2 and on how selection can shape its genome toward adaptation to new environments. Lay Summary: Each time a virus replicates inside a cell, errors (mutations) occur. Here, via laboratory propagation in cells originally isolated from the kidney epithelium of African green monkeys, we estimated the rate at which the SARS-CoV-2 virus mutates-an important parameter for understanding how it can evolve within and across humans. We also confirm the potential of its Spike protein to adapt to a new environment and report the emergence of mutators-viral populations where mutations occur at a significantly faster rate.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Evolution, Medicine, and Public Health
Evolution, Medicine, and Public Health Environmental Science-Health, Toxicology and Mutagenesis
CiteScore
5.40
自引率
2.70%
发文量
37
审稿时长
8 weeks
期刊介绍: About the Journal Founded by Stephen Stearns in 2013, Evolution, Medicine, and Public Health is an open access journal that publishes original, rigorous applications of evolutionary science to issues in medicine and public health. It aims to connect evolutionary biology with the health sciences to produce insights that may reduce suffering and save lives. Because evolutionary biology is a basic science that reaches across many disciplines, this journal is open to contributions on a broad range of topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信